References
- Nudelman Y, Tunkel AR. Bacterial meningitis: epidemiology, pathogenesis and management update. Drugs. 2009;69:2577–96.
- Shin SH, Kim KS. Treatment of bacterial meningitis: an update. Expert Opin Pharmacother. 2012;13:2189–206.
- Marchese A, Esposito S, Barbieri R, Bassetti M, Debbia E. Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections? BMC Infect Dis. 2012;12:181–189.
- Marchese A, Schito GC. Recent findings from multinational resistance surveys: are we “PROTEKTed” from resistance? Int J Antimicrob Agents. 2007:29 Suppl 1:S2–5.
- Marchese A, Ardito F, Fadda G, Fontana R, Lo Cascio G, Nicoletti G, et al. The Sentinel Project: an update on the prevalence of antimicrobial resistance in community-acquired respiratory Streptococcus pneumoniae and Haemophilus spp. in Italy. Int J Antimicrob Agents. 2005;26:8–12.
- Enright M, Spratt BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology. 1998;144:3049–60.
- Available from http://www.cdc.gov/ncidod/biotech/strep/pcr.htm and from: http://www.cdc.gov/ncidod/biotech/files/pcr-US-clinical-specimens.pdf.
- Available at http://spneumoniae.mlst.net/.
- Vanderkooi OG, Low DE, Green K, Powis JE, McGeer A, Toronto Invasive Bacterial Disease Network. Predicting antimicrobial resistance in invasive Pneumococcal infections. Clin Infect Dis. 2005;40:1288–97.
- Chaudhuri A, Martinez-Martin P, Kennedy PG, Andrew Seaton R, Portegies P, Bojar M, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008;15:649–59.
- Sipahi OR, Bardak S, Turhan T, Arda B, Pullukcu H, Ruksen M, et al. Linezolid in the treatment of methicillin-resistant staphylococcal post-neurosurgical meningitis: a case series of 17 cases. Scand J infect Dis. 2011;43:757–64.
- Knoll BM, Hellmann M, Kotton CN. Vancomycin-resistant Enterococcus faecium meningitis in adults: case series and review of the literature. Scand J Infect Dis. 2013;45:131–9.
- Boak LM, Li J, Spelman D, du Cros P, Nation RL, and Rayner CR. Successful treatment and cerebrospinal fluid penetration of oral linezolid in a patient with coagulase-negative Staphylococcus ventriculitis. Ann Pharmacother. 2006; 40:1451–5.
- Dong H, Wang X, Dong Y, Lei J, Li H, You H, et al. Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill intensive care unit patients. Int J Antimicrob Agents. 2011;38:296–300.
- Pea F, Pavan F, Nascimben E, Benetton C, Scotton PG, Vaglia A et al. Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy. Antimicrob Agents Chemother. 2003;47:3104–8.
- Albanèse J, Léone M, Bruguerolle B, Ayem ML, Lacarelle B, Martin C. Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit. Antimicrob Agents Chemother. 2000;44:1356–8.
- Jorgenson L, Reiter PD, Freeman JE, Winston KR, Fish D, McBride LA, et al. Vancomycin disposition and penetration into ventricular fluid of the central nervous system following intravenous therapy in patients with cerebrospinal devices. Pediatr Neurosurg. 2007;43:449–55.